Personalised treatment in melanoma: matching optimal drug therapies for individual patients to improve survival. [ 11/1/2021 - 10/31/2027 ]

Research Grant

Brief description The best treatment for melanoma currently is immunotherapy. However, most patients become resistant to immunotherapy after an initial response. When this occurs, patients are treated with new medications, often in a clinical trial. Unfortunately, doctors cannot predict if a patient is going to respond to a particular new treatment. This project will study the makeup of individual melanomas and use this to recommend which new treatment is most likely to work for the patient.

Funding Amount $132,743

Funding Scheme Postgraduate Scholarships

Chief Investigator Dr Prachi Bhave

Notes Clinical Medicine and Science Research Scholarship